KYMR
Kymera Therapeutics·NASDAQ
--
--(--)
--
--(--)
KYMR Filings
Filing Date
Form Description
Form Type
2025-12-17
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-17 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-17
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-17 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-17
Form 144 - Report of proposed sale of securities
Ownership
2025-12-17 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-15
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-12-15 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-12-12
Form 144 - Report of proposed sale of securities
Ownership
2025-12-12 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-12
Form 144 - Report of proposed sale of securities
Ownership
2025-12-12 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-11
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-12-11 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-12-11
Form 144 - Report of proposed sale of securities
Ownership
2025-12-11 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-11
Form 144 - Report of proposed sale of securities
Ownership
2025-12-11 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-10
Form 144 - Report of proposed sale of securities
Ownership
2025-12-10 · Ownership
Form 144 - Report of proposed sale of securities
